The evolving pattern of digoxin intoxication: Observations at a large urban hospital from 1980 to 1988

American Heart Journal

Volumn 120, Issue 5, 1990, Pages 1189-1194

  Mahdyoon, Hooman ^a   Battilana, Guido ^a   Rosman, Howard ^a   Goldstein, Sidney ^a   Gheorghiade, Mihai ^a  

^a HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN;

ARTICLE; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; VOMITING;

AGED; AGED, 80 AND OVER; ARRHYTHMIA; DIGOXIN; FEMALE; HOSPITALS, URBAN; HUMAN; MALE; MICHIGAN; POISONING; RETROSPECTIVE STUDIES;

EID: 0025092810     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(90)90135-K     Document Type: Article

References (45)

1. Digitalis glycosides mechanisms and manifestations of toxicity
2. Digitalis glycosides: mechanisms and manifestations of toxicity. II. Basic mechanisms of cardiac glycoside action
3. Toxicity—a frequent complication of digitalis therapy
4. Adverse drug reactions during hospitalization
5. The epidemiology of digoxin: a study in three Boston hospitals
6. Intensive hospital monitoring of adverse reactions to drugs
7. Digitalis intoxication: a comparative study on the incidence of digitalis intoxication during the periods 1950–1952 and 1964–1966
8. Plasma digoxin concentrations and digoxin toxicity in hospital patients
9. Digitalis intoxication: a prospective clinical study with serum level correlations
10. A prospective survey of the incidence of cardiac intoxication with digitalis in patients being admitted to hospital and correlation with serum digoxin levels
11. Digitalis glycosides
12. Serum digoxin and empiric methods in identification of digitoxicity
13. Studies on digitalis. XIII. A prospective study of 649 patients on maintenance treatment with digitoxin
14. Bioavailability of digoxin
15. Reduction of toxicity associated with measurement of serum levels
16. Pharmacokinetic interactions between digoxin and other drugs
17. Should digoxin be the drug of first choice after diuretics in chronic congestive heart failure? II. Protagonist's viewpoint
18. Digitalis: mechanisms of action and clinical use
19. Treatment of life threatening digitalis intoxication with dogoxin-specific FAB fragments: experience in 26 cases
20. Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration
21. Incidence of digitalis intoxication
22. Should digoxin be the drug of first choice after diuretics in chronic congestive heart failure? I. Introduction
23. Digitalis
24. Should digoxin be the drug of first choice after diuretics in chronic congestive heart failure? Antagonist's viewpoint
25. Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially traeted with diuretics and vasodilators
26. Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure
27. Comparative effects of captopril and digoxin in patients with mild to moderate heart failure
28. A comparison of oral milrinone, digoxin and their combination in the treatment of patients with chronic heart failure
29. Long-term digitalis therapy improves left ventricular function in heart failure
30. Heart failure in outpatients: a randomized trial of digoxin versus placebo
31. Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients
32. Effect of digoxin on ejection fraction in elderly patients with congestive heart failure
33. Physician practice in the management of congestive heart failure
34. Digitalis-associated cardiac mortality after myocardial infarction
35. Effect of digitalis treatment on survival after acute myocardial infarction
36. The effects of digitalis on survival in high-risk patients with coronary artery disease
37. Prognostic importance of digitalis after acute myocardial infarction
38. Association of digitalis therapy with mortality in survivors of acute myocardial infarction: observations in the Beta-Blocker Heart Attack Trial
39. Digoxin therapy and mortality after myocardial infarction: experience in the MILIS study
40. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies
41. Digoxin-specific antibody treatment of digitalis toxicity: update
42. Foxglove and Fab: immunological approaches to digitalis intoxication
43. Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments
44. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific FAB antibody fragments